Immuron (IMRN) Cash & Equivalents (2016 - 2025)

Immuron's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $28305.3 for Q3 2025.

• In Q3 2025, Cash & Equivalents fell 75.72% year-over-year to $28305.3; the TTM figure through Sep 2025 stood at $28305.3 (down 75.72% YoY), while the FY2025 annual figure was $11.7 million, down 32.07% from the prior year.
• Cash & Equivalents for Q3 2025 stood at $28305.3, down from $1.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $19.3 million in Q2 2021, with the low at $28305.3 in Q3 2025.
• The 5-year median for Cash & Equivalents is $9.4 million (2023), against an average of $9.1 million.
• The sharpest annual moves came in 2021 and 2023: Cash & Equivalents soared 6833.34% in 2021, then tumbled 98.88% in 2023.
• Immuron's Cash & Equivalents stood at $18.3 million in 2021, then fell by 20.77% to $14.5 million in 2022, then retreated by 23.1% to $11.2 million in 2023, then sank by 31.76% to $7.6 million in 2024, then sank by 99.63% to $28305.3 in 2025.
• Business Quant data shows IMRN's Cash & Equivalents at $28305.3 in Q3 2025, $1.8 million in Q2 2025, and $7.6 million in Q4 2024.